[IPO 워치] 레메디, 세 번째 상장 도전…글로벌 수주가 밸류 관건

Remedi's third IPO attempt highlights the growing market for portable X-ray technology in emerging healthcare sectors, backed by NASA validation and major Indian government contracts. However, investors must assess whether the company can convert these public procurement orders into reliable revenue growth, and whether the nascent portable X-ray market will achieve its projected 20-fold expansion by 2034.